BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.410
-0.040 (-1.16%)
At close: Aug 12, 2026, 4:00 PM EDT
3.500
+0.090 (2.64%)
After-hours: Aug 12, 2026, 7:49 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $29.62 million as of August 12, 2026. Its market cap has increased by 530.30% in one year.
Market Cap
29.62M
Enterprise Value
6.69M
1-Year Change
530.30%
Ranking
Category
Stock Price
$3.41
ChartMarket Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has increased from $26.00M to $29.62M, an increase of 13.94%. That is a compound annual growth rate of 2.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 29.62M | 121.08% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 32.25M |
| Estrella Immunopharma | 32.06M |
| Lite Strategy | 31.35M |
| NanoViricides | 31.21M |
| Genenta Science | 30.67M |
| Quince Therapeutics | 30.57M |
| BeyondSpring | 30.51M |
| Enlivex | 29.57M |